Drug intelligence / Profile preview

autologous human umbilical cord blood

Development stage: Unknown
Lead developer: University of Texas Health Science Center at Houston
Modality: Stem Cell Therapies → Cell Therapies
Administration: Intravenous

Overview

An investigational autologous cellular therapy consisting of mononuclear cells derived from a patient's own banked umbilical cord blood. Developed by Dr. Charles S. Cox Jr. at the University of Texas Health Science Center at Houston, this biologic treatment is being evaluated for pediatric patients with moderate to severe traumatic brain injury (TBI). The therapy involves a single intravenous infusion of the banked cells, which are believed to exert therapeutic effects by modulating the systemic inflammatory response and providing neuroprotection to damaged brain tissue. The treatment is specifically designed for patients who have previously banked their own umbilical cord blood, ensuring immunological compatibility.

Other names: autologous cord bloodhUCBautologous human umbilical cord blood-derived mononuclear cells

Beyond the preview

Go deeper on autologous human umbilical cord blood.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on autologous human umbilical cord blood.

Explore the full profile